Data gathered: October 25
Alternative Data for United Therapeutics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 53 | Sign up | Sign up | Sign up |
| Sentiment | 91 | Sign up | Sign up | Sign up |
| Webpage traffic | 30,000 | Sign up | Sign up | Sign up |
| Employee Rating | 78 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | 93 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 21 | Sign up | Sign up | Sign up |
| Facebook Followers | 1,565 | Sign up | Sign up | Sign up |
| Instagram Followers | 73 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 23 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,410 | Sign up | Sign up | Sign up |
| Twitter Followers | 192 | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| X Mentions | 6 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 70 | Sign up | Sign up | Sign up |
| Linkedin Employees | 1,352 | Sign up | Sign up | Sign up |
About United Therapeutics
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.
| Price | $418.58 |
| Target Price | Sign up |
| Volume | 378,720 |
| Market Cap | $19.3B |
| Year Range | $274.7 - $456.84 |
| Dividend Yield | 0% |
| PE Ratio | 16.64 |
| Analyst Rating | 73% buy |
| Earnings Date | October 29 '25 |
| Industry | Biotechnology |
In the news
 |
United Therapeutics (UTHR) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseOctober 22 - Yahoo |
 |
If You Invested $100 In United Therapeutics Stock 15 Years Ago, You Would Have This Much TodayOctober 21 - Biztoc.com |
|
Why The Narrative Around United Therapeutics Is Shifting After Major Clinical and Pipeline UpdatesOctober 18 - Yahoo |
|
Jefferies Reiterates Buy Rating on United Therapeutics (UTHR) Amid Patent CaseOctober 16 - Yahoo |
|
United Therapeutics Corporation to Report Third Quarter 2025 Financial Results Before Market Open on Wednesday, October 29, 2025October 14 - Yahoo |
|
United Therapeutics to Feature Clinical Data at the CHEST 2025 Annual MeetingOctober 12 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '25 | 799M | 88M | 711M | 310M | 437M | 6.410 |
| Q1 '25 | 794M | 93M | 702M | 322M | 383M | 6.630 |
| Q4 '24 | 736M | 76M | 660M | 301M | 424M | 6.190 |
| Q3 '24 | 749M | 83M | 666M | 309M | 418M | 6.390 |
| Q2 '24 | 715M | 78M | 637M | 278M | 339M | 5.850 |
Insider Transactions View All
| ROTHBLATT MARTINE A filed to sell 3,496 shares at $420.5. October 22 '25 |
| ROTHBLATT MARTINE A filed to sell 130 shares at $423.1. October 22 '25 |
| ROTHBLATT MARTINE A filed to sell 1,296 shares at $422.2. October 22 '25 |
| ROTHBLATT MARTINE A filed to sell 130 shares at $432.2. October 22 '25 |
| ROTHBLATT MARTINE A filed to sell 630 shares at $430.4. October 22 '25 |
Similar companies
Read more about United Therapeutics (UTHR) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, x mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of United Therapeutics?
The Market Cap of United Therapeutics is $19.3B.
What is United Therapeutics' PE Ratio?
As of today, United Therapeutics' PE (Price to Earnings) ratio is 16.64.
When does United Therapeutics report earnings?
United Therapeutics will report its next earnings on October 29 '25.
What is the current stock price of United Therapeutics?
Currently, the price of one share of United Therapeutics stock is $418.58.
How can I analyze the UTHR stock price chart for investment decisions?
The UTHR stock price chart above provides a comprehensive visual representation of United Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling United Therapeutics shares. Our platform offers an up-to-date UTHR stock price chart, along with technical data analysis and alternative data insights.
Does UTHR offer dividends to its shareholders?
As of our latest update, United Therapeutics (UTHR) does not offer dividends to its shareholders. Investors interested in United Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of United Therapeutics?
Some of the similar stocks of United Therapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.
